September 19-20 2024

Dear All, 

It is our pleasure to announce the WG1 WG2 HG7 Thematic Workshop:   " Novel leads and drugs for vector borne diseases: Targets and off targets (toxicity and ecotoxicity) and mechansim of action” that will take place next September 19-20 2024 at the National Hellenic Research Foundation, Athens, Greece.

The official anouncement will soon be published, as the workshop is open to all scientists.

As usual, we will do our best to support as many attendants as possible. For that we need to proceed in two directions. In one side we have to finish the reimboursements for june and july events (Naples training school, Rome YRI workshop and Ofxord Conference). If you attended any of them as "eligible for reimboursement", please proceed claiming your expenses ASAP.  

In the other side we would like to know who is planning to attend the Athens Workshop and how much that will cost. 

PREREGISTRATION before August 5th can be performedhttps://docs.google.com/forms/d/e/1FAIpQLSflZJMFa4m6QXa5B9ZxXCZp8doOurXLk2pJh71SK9rPziJaHw/viewform?usp=sharing

In case you need a letter for VISA application, please write the letter yourself and send it to the Chair (Maria Paola COSTI ) who will follow up on that with you.

-----------------

Description

We are excited to announce the international workshop “Novel leads and drugs for vector borne diseases: Targets and off targets (toxicity and ecotoxicity) and mechanism of action” organized in the context of the COST ACTION 2111-OneHealthdrugs – “One Health drugs against parasitic vector borne diseases in Europe and beyond”. The COST Action network aims to coordinate the discovery of drugs that stop vector-borne infections in both human and veterinary settings according to the principles of the optimal profile for these organisms, increasing quality and reducing environmental impact. 

The workshop will be held from Thursday, September 19th, to Friday, September 20th ,2024, in Athens, Greece, at the National Hellenic Research Foundation. The workshop is jointly organized by WG1 “Compound libraries coordination and integration of compound design”, WG2 “Integration of early phase studies and low environmental impact actions”, and HG7 “Drug chemistry advancements in biodegradability including prediction” of the COST Action CA21111 OneHealthDrugs.

The workshop seeks to provide up to date information and integration strategy on sustainable drug discovery for vector borne diseases (VBDs). Special emphasis will also be given to new targets for VBDs and methods to study their engagement as well as on biodegradability and toxicity aspects pinpointing the effect on the environment. This collaborative event will provide a platform for scientists, academics, and industry professionals to share insights, methodologies, and advancements in the pursuit of environmentally conscious antiparasitic drug discovery. 

We look forward to your participation and the submission of your abstract and we are delighted to welcome you in Athens to this intellectually rewarding meeting.

With warm regards, 

The Scientific Committee

Theodora Calogeropoulou, National Hellenic Research Foundation, Athens, Greece

Ulrike Wittig, Heidelberg Institute for Theoretical Studies, Heidelberg, Germany

Sandra Gemma, University of Siena, Siena, Italy

Maria Paola Costi, University of Modena and Reggio Emilia

Anabela Cordeiro da Silva

The Local Organising Committee

Theodora Calogeropoulou

Ioannis Papanastastiou

George E. Magoulas

Theano Fotopoulou

 

 

 

Abstract template

Preliminary Programme_Novel leads and drugs for vector borne diseases: Targets and off targets (toxicity and ecotoxicity) and mechanism of action

COST
What is COST?

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

OneHealthdrugs CA21111
Title:

One Health drugs against parasitic vector borne diseases in Europe and beyond

Acronym:

OneHealthdrugs

Start date of the Action:

24/10/2022

End date of the Action:

23/10/2026

CSO approval date:

27/05/2022

Memorandum of Understanding (MoU)

Download file

Contact Points
Chair:

Maria Paola Costi

Vice-Chair:

Anabela Cordeiro da Silva

COST staff

Scientific Officer:
Lucia Forzi
Administrative Officer:
Nathalie Warenghien

Administrative Team

Maria Cristina Notarsanto
Maria Esposito and Laura Leonardi